Document:

Employement Offer Letter

 Exhibit 10.70 

 
 

 
 2929 SEVENTH STREET, SUITE 100 

BERKELEY, CALIFORNIA 94710 
 Sent via Federal Express 
 August 1, 2012 

Christine Larson 
  

	Re:	Employment Terms 

 Dear Chris: 

Dynavax Technologies Corporation (“Dynavax” or the “Company”) is pleased to offer you the position of Vice President and Chief
Financial Officer, on the following terms. 
 You will be responsible for providing strategic leadership and operational management oversight of
the finance and accounting organization of the Company, and other duties as assigned. You will report to Dino Dina, MD and work at our facility located at 2929 Seventh Street, Suite 100 in Berkeley, California. The Company may change your position,
duties, and work location from time to time as it deems necessary. 
 Your compensation will be $29,166.66 per month, annualized to $350,000,
less payroll deductions and all required withholdings. You will be paid semi-monthly, and will be eligible for the following standard Company benefits: medical insurance for yourself and your family (there will be an employee contribution for
dependent coverage), 12 holidays per year, life insurance, disability insurance, long-term care insurance, Flexible Spending Account, 401(k), and Employee Stock Purchase Plan. The Company may modify compensation and benefits from time to time as it
deems necessary. 
 Personal time off is not accrued or tracked for members of the executive team. The attached Personal Time-Off Policy
highlights the time off you have to use each year. Also, you and your eligible dependents will be covered under the Exec-U-Care medical reimbursement plan. This plan supplements your health insurance up to $50,000 per employee or family unit for
unreimbursed medical expenses during a calendar year. 
 As a member of the executive team, you are eligible for a 50% target annual incentive
bonus, based on your performance measured against corporate, individual and project milestones to be proposed by the company and mutually agreed upon by the parties by no later than thirty days from your start date with Dynavax. Annual incentive
bonus targets are typically reviewed and approved by the Company’s Compensation Committee in the first quarter of the following year, and payout of the bonuses are at the discretion of the Company’s board of directors. To receive an
incentive bonus payment, an eligible participant in the program must be an active employee on the date the bonus is paid. 
 The Company will
grant you a stock option to purchase 300,000 shares of the Common Stock of the Company, with an exercise price equal to the fair market value of the Common Stock on the date of grant. This stock option is subject to all of the terms and conditions
set forth in the applicable award agreement and applicable stock incentive plan. Your stock option grant of 300,000 shares of the Common Stock of the Company will vest as follows: 25% of the Shares subject to the Option shall vest twelve months
after the Vesting Commencement Date, and 1/48 of the Shares subject to the Option shall vest on the last day of each month, provided that vesting shall cease upon termination of your continuous service to the Company. 

  
  

 

							
	PHONE:    510-848-5100	  	TOLL-FREE:    877-848-5100	  	FAX:    510-848-1327	  	WWW.DYNAVAX.COM

 

 
 Christine Larson 
 August 1, 2012 
  Page
 2
 
  

 This offer is subject to your submission, no later than three days after your employment begins, of an
I-9 form and satisfactory documentation regarding your identification and right to work in the United States. 
 Your employment is contingent
upon the acceptable results of a background check, including Social Security number, education, and employment verification Any falsification of an applicant’s employment history or educational background will result in withdrawal of the offer
and/or termination of employment, if hired. 
 As an employee of the Company, you will be expected to abide by Company rules and regulations,
and to sign and comply with a Proprietary Information and Inventions Agreement, which prohibits unauthorized use or disclosure of the Company’s proprietary information. 
 Normal working hours are from 8:00 a.m. to 5:00 p.m., Monday through Friday. As an exempt salaried employee, you will be expected to work additional hours as required by the nature of your work
assignments. 
 You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company
Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice. This at-will employment relationship cannot be changed except by written agreement signed by a Company officer.

 The employment terms in this letter and your management continuity and severance agreement supersede any other agreements or promises made to
you by anyone, whether oral or written. 
 Please sign and date one copy of this letter and return it in the enclosed envelope to Cecilia Vitug,
VP of Human Resources, if you accept our offer of employment A mutually acceptable start date can be agreed upon after you accept our offer of employment. 
 Chris, we look forward to a positive reply and productive and enjoyable work relationship if you join the Company. 
  

	
	Sincerely,
	
	 /s/ Dino Dina

	Dino Dina, MD
	Chief Executive Officer
	
	Accepted:
	
	 /s/ Christine Larson

	Christine Larson
	
	 August 6, 2012

	DateConsulting Agreement

 Exhibit 10.71 
 CONSULTING AGREEMENT 
 THIS CONSULTING
AGREEMENT (“Agreement”) is entered into as of May 1, 2012, by and between Frank Cano (“Consultant”) and Dynavax Technologies Corporation (“Dynavax”). 

RECITALS 
 A. Consultant possesses expertise relating to the field of manufacturing (“the Field”) and/or otherwise relating to the business of Dynavax. 

B. Dynavax desires that Consultant provide Dynavax with certain consulting services requiring expertise in the Field, and Consultant
desires to provide such consulting services, as set forth in this Agreement. 
 TERMS 

NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants
and agreements set forth herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto agree as follows: 
 1. ENGAGEMENT OF SERVICES. Effective as of the date hereof, Consultant will be retained by Dynavax to provide the services described on Exhibit A
attached hereto, as requested by Dynavax (“Services”). Consultant agrees to be available to provide the Services at such times and locations as reasonably required by Dynavax, for the amount of time each month as may be set forth on
Exhibit A or otherwise as necessary to perform the Services pursuant to this Agreement. The manner and means by which Consultant chooses to complete the Services are in Consultant’s sole discretion and control. Consultant agrees to exercise the
highest degree of professionalism in providing such Services. In providing the Services, Consultant agrees, as necessary and unless otherwise provided by Dynavax in its discretion, to provide the equipment, tools, and other materials required at
Consultant’s own expense; and Dynavax will make its facilities and equipment available to Consultant when necessary. Dynavax shall be responsible for all reasonable travel expenses incurred by Consultant in performing Services under this
Agreement. Consultant shall perform the Services necessary in a timely and professional manner consistent with industry standards at a location, place, and time which the Consultant deems appropriate. 

2. FEES AND TAXES. Consultant shall be paid fees
for the Services as described on Exhibit B hereto. Consultant shall issue monthly invoices to Dynavax for work already performed. Dynavax shall pay Consultant net 30 days from receipt of invoice. Consultant will include with invoices receipts for
reimbursable travel expenses and will itemize such travel expenses on the invoice. Invoices must be received within six (6) months of the date services are provided. Company will not be obligated to pay any invoices received more than six
(6) months after the date of service. 

  
 Page 1

 Because Consultant is an independent contractor, Dynavax will not withhold or make payments
for state or federal income tax or Social Security (except if required by California state law); make unemployment insurance or disability insurance contributions; or obtain workers’ compensation insurance on Consultant’s behalf. Dynavax
will issue Consultant a 1099 form with respect to Consultant’s consulting fees. Consultant agrees to accept exclusive liability for complying with all applicable state and federal laws governing self-employed individuals, including obligations
such as payment of quarterly taxes, Social Security, disability, and other contributions based on the fees paid to Consultant, its agents, or employees under this Agreement. Consultant hereby indemnifies and defends Dynavax against any and all such
taxes or contributions. 
 2. CONSULTANT NOT AN EMPLOYEE.
Consultant agrees that it is the express intention of both Consultant and Dynavax that Consultant is an independent contractor and not an employee, agent, joint venturer, or partner of Dynavax. Consultant agrees not to give any person or entity any
reason to believe that Consultant is an employee, agent, joint venturer, or partner of Dynavax. Consultant agrees not to bind Dynavax, unless expressly authorized by Dynavax in writing. Consultant will not receive any employee benefits such as paid
holidays, vacations, sick leave, or other such paid time off, or participate in Dynavax-sponsored health insurance or other employee benefit plans. 
 3. PROPRIETARY INFORMATION AND INVENTIONS. Consultant agrees to abide by the Consultant Proprietary Information and Inventions Agreement
and/or Non- Disclosure Agreement entered into between Dynavax and Consultant in connection herewith, and that a material breach of such agreement shall constitute a material breach hereunder. 

4. TERMINATION. This Agreement shall be effective as of the date hereof and shall continue until December 31,
2012, unless terminated earlier as set forth in this paragraph. Either Dynavax or Consultant may terminate this Agreement at any time by giving the other party thirty (30) days written notice. 

5. GENERAL. This Agreement shall bind the heirs, personal representatives, successors, assigns, executors, and
administrators of both Consultant and Dynavax, and inure to the benefit of both Consultant and Dynavax, their heirs, successors, and assigns. This Agreement constitutes the complete, final, and exclusive embodiment of the entire agreement between
Consultant and Dynavax with respect to the terms and conditions of the subject matter hereof. This Agreement is entered into without relying upon any promise, warranty, or representation, written or oral, other than those expressly contained in this
Agreement, and it supersedes any other such promises, warranties, representations, or agreements. This Agreement may not be amended or modified except by a written instrument signed by both Consultant and a duly authorized officer of Dynavax. This
Agreement shall be construed and interpreted in accordance with the laws of the State of California, as such laws are applied to contracts executed and performed entirely within California. If any provision of this Agreement is determined to be
invalid or unenforceable, in whole or in part, this 

  
 Page 2

 
determination will not affect any other provision of this Agreement. A failure of either Consultant or Dynavax to enforce at any time or for any period of time the provisions of this Agreement
shall not be construed to be a waiver of such provisions or of the right of Consultant or Dynavax to enforce each and every such provision. 
 6. ARBITRATION. Any controversy, dispute or claim arising out of, in connection with, or in relation to the interpretation or performance of this Agreement shall be resolved through
binding and nonappealable arbitration administered by the Judicial Arbitration & Mediation Services, Inc. (“JAMS”) in San Francisco County, California. Any such arbitration shall be conducted before a single arbitrator to be
appointed by the parties from JAMS’ roster. If the parties fail to agree to as to the identity of the single arbitrator, JAMS shall have the right to make such appointment. The conduct of the arbitration hearing and discovery prior thereto
shall be in accordance with the California Code of Civil Procedure, California Rules of Court, and California Rules of Evidence. There shall be limited discovery prior to the arbitration hearing, subject to the discretion of the arbitrator, as
follows: (a) exchange of witness lists and copies of documentary evidence and documents related to or arising out of the issues to be arbitrated, (b) depositions of all party witnesses, and (c) such other depositions as may be allowed
by the arbitrator upon a showing of good cause. The nonprevailing party shall pay the prevailing party’s costs and expenses (including attorneys’ fees) of any such arbitration. Consultant and Dynavax shall bear equally the fees and
expenses of the arbitrator. The arbitrator shall decide the matter to be arbitrated pursuant hereto within 60 days after the appointment of the arbitrator. 
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above. 

 

									
	AGREED TO:	 		 	AGREED TO:
	Dynavax Technologies Corporation	 		 	
					
	By:	 	 /s/ Tyler Martin
	 		 	By:	 	 /s/ Frank Cano

		 	Tyler Martin	 		 		 	Frank Cano
					
	Date:	 	 1 MAY 2012
	 		 	Date:	 	 5/1/12

				
	Dynavax Technologies	 		 		 	
	2929 Seventh Street, Suite 100	 		 	
	Berkeley, CA 94710	 		 	
	Telephone: 510-848-5100	 		 	
	Fax:	 		 	
	Email: tmartin@dynavax.com	 		 	

  
 Page 3

 EXHIBIT A 
 SCOPE OF SERVICES 

CONSULTANT WILL BE ON-SITE 2-DAYS PER
WEEK AS NEEDED, TO PROVIDE MANAGEMENT GUIDANCE IN THE MANUFACTURING AREA
AND AS LIAISON FOR THE BOARD WITH THE CEO AND PRESIDENT. 

  
 Page 4

 EXHIBIT B 
 CONSULTING FEES 
 CONSULTANT
FEES IS $10,000 PER MONTH FOR ON-SITE SERVICES 2-DAYS PER WEEK. 

NET: 30-DAYS 
 MAXIMUM: NOT TO EXCEED $120,000 

  
 Page 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]